258 related articles for article (PubMed ID: 25576061)
1. Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease.
Willette AA; Modanlo N; Kapogiannis D;
Diabetes; 2015 Jun; 64(6):1933-40. PubMed ID: 25576061
[TBL] [Abstract][Full Text] [Related]
2. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.
Willette AA; Bendlin BB; Starks EJ; Birdsill AC; Johnson SC; Christian BT; Okonkwo OC; La Rue A; Hermann BP; Koscik RL; Jonaitis EM; Sager MA; Asthana S
JAMA Neurol; 2015 Sep; 72(9):1013-20. PubMed ID: 26214150
[TBL] [Abstract][Full Text] [Related]
3. The use of individual-based FDG-PET volume of interest in predicting conversion from mild cognitive impairment to dementia.
Huang SH; Hsiao WC; Chang HI; Ma MC; Hsu SW; Lee CC; Chen HJ; Lin CH; Huang CW; Chang CC
BMC Med Imaging; 2024 Mar; 24(1):75. PubMed ID: 38549082
[TBL] [Abstract][Full Text] [Related]
4. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer's disease using FDG-PET.
Mosconi L; De Santi S; Li Y; Li J; Zhan J; Tsui WH; Boppana M; Pupi A; de Leon MJ
Eur J Nucl Med Mol Imaging; 2006 Feb; 33(2):210-21. PubMed ID: 16311757
[TBL] [Abstract][Full Text] [Related]
5. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
7. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
[TBL] [Abstract][Full Text] [Related]
8. Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.
Roy K; Pepin LC; Philiossaint M; Lorius N; Becker JA; Locascio JJ; Rentz DM; Sperling RA; Johnson KA; Marshall GA
J Alzheimers Dis; 2014; 42(1):291-300. PubMed ID: 24898635
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.
Baker LD; Cross DJ; Minoshima S; Belongia D; Watson GS; Craft S
Arch Neurol; 2011 Jan; 68(1):51-7. PubMed ID: 20837822
[TBL] [Abstract][Full Text] [Related]
10. Autotaxin is Related to Metabolic Dysfunction and Predicts Alzheimer's Disease Outcomes.
McLimans KE; Willette AA;
J Alzheimers Dis; 2017; 56(1):403-413. PubMed ID: 27911319
[TBL] [Abstract][Full Text] [Related]
11. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
[TBL] [Abstract][Full Text] [Related]
13. Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.
Wu L; Rowley J; Mohades S; Leuzy A; Dauar MT; Shin M; Fonov V; Jia J; Gauthier S; Rosa-Neto P;
PLoS One; 2012; 7(10):e47905. PubMed ID: 23112868
[TBL] [Abstract][Full Text] [Related]
14. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
Mosconi L
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
[TBL] [Abstract][Full Text] [Related]
15. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
16. Precuneus and Cingulate Cortex Atrophy and Hypometabolism in Patients with Alzheimer's Disease and Mild Cognitive Impairment: MRI and (18)F-FDG PET Quantitative Analysis Using FreeSurfer.
Bailly M; Destrieux C; Hommet C; Mondon K; Cottier JP; Beaufils E; Vierron E; Vercouillie J; Ibazizene M; Voisin T; Payoux P; Barré L; Camus V; Guilloteau D; Ribeiro MJ
Biomed Res Int; 2015; 2015():583931. PubMed ID: 26346648
[TBL] [Abstract][Full Text] [Related]
17. What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?
Andriuta D; Moullart V; Schraen S; Devendeville A; Meyer ME; Godefroy O;
J Alzheimers Dis; 2016; 51(3):793-800. PubMed ID: 26923012
[TBL] [Abstract][Full Text] [Related]
18. Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD.
Richter N; Nellessen N; Dronse J; Dillen K; Jacobs HIL; Langen KJ; Dietlein M; Kracht L; Neumaier B; Fink GR; Kukolja J; Onur OA
Neuroimage Clin; 2019; 24():101978. PubMed ID: 31422337
[TBL] [Abstract][Full Text] [Related]
19. Disruption of limbic white matter pathways in mild cognitive impairment and Alzheimer's disease: a DTI/FDG-PET study.
Bozoki AC; Korolev IO; Davis NC; Hoisington LA; Berger KL
Hum Brain Mapp; 2012 Aug; 33(8):1792-802. PubMed ID: 21674695
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment.
Kemppainen N; Joutsa J; Johansson J; Scheinin NM; Någren K; Rokka J; Parkkola R; Rinne JO
J Alzheimers Dis; 2015; 48(1):123-33. PubMed ID: 26401934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
